Human Metapneumovirus (HMPV): Symptoms and Treatment

Human Metapneumovirus (hMPV) is a virus that causes mild to severe upper respiratory infections, including cold-like symptoms. Learn more about hMPV's impact.
Explore Plans
Check Health Insurance Plans
Get Quote
3 min
14-January-2025

Human metapneumovirus (HMPV) is a respiratory infection caused by a virus belonging to the Paramyxoviridae family. It primarily affects the lungs and airways and can lead to serious illness, especially in vulnerable populations. HMPV infections are common in both adults and children, particularly during the winter months. In many cases, symptoms resemble other viral respiratory illnesses, making it challenging to diagnose without proper medical testing. Although the condition can range from mild to severe, prompt treatment and preventive measures can help mitigate the impact. This article will explore the symptoms, causes, diagnosis, treatment options, and prevention tips for HMPV, providing valuable insights for individuals and healthcare professionals, particularly in India, where respiratory diseases are a major health concern.

What is human metapneumovirus (HMPV)

Human metapneumovirus (HMPV) is a virus that primarily causes respiratory infections. It is part of the Paramyxovirus family, closely related to the respiratory syncytial virus (RSV) and affects both children and adults. The virus typically targets the respiratory system, leading to infections in the upper and lower airways, including the nose, throat, and lungs. HMPV infections can range from mild cold-like symptoms to severe conditions, such as bronchiolitis or pneumonia, especially in infants, older adults, or individuals with compromised immune systems.

The virus spreads through respiratory droplets when an infected person coughs, sneezes, or talks. HMPV infections are most common during the winter and early spring months, though they can occur year-round. Like other respiratory viruses, HMPV can cause outbreaks in schools, healthcare facilities, and households. Understanding the nature of HMPV, its transmission, and how it differs from other respiratory infections is crucial for proper management and prevention.

Is human metapneumovirus (HMPV) the same as a cold?

Human metapneumovirus (HMPV) is not just a common cold. While it shares similar symptoms, it can cause more severe respiratory issues, especially in vulnerable groups like young children, the elderly, and those with weakened immune systems.

How prevalent is human metapneumovirus (HMPV)?

Human metapneumovirus (HMPV) is relatively widespread and plays a significant role in respiratory infections globally. It is most common in late winter and spring, particularly affecting young children, the elderly, and those with weakened immune systems. Most people experience mild cold-like symptoms from the virus during their lifetime.

Symptoms of human metapneumovirus (HMPV)

Age and health-related variations:

Symptoms vary based on age, health status, and immune strength.

  • In children and infants: Symptoms tend to be more severe, with potential for complications.
  • In adults: Symptoms are generally milder, resembling a common cold.

Primary symptoms:

  • Persistent cough: A key indicator of HMPV infection.
  • Mild to moderate fever: Common alongside the cough.
  • Nasal congestion or runny nose: Contributes to discomfort and breathing difficulty.
  • Early-stage symptoms: Sore or scratchy throat, frequently experienced in the initial stages of infection.

Severe symptoms:

  • Wheezing and difficulty breathing: More common in vulnerable populations, such as young children or the elderly, as HMPV affects the airways and lungs.
  • Fatigue and weakness: Individuals may feel generally unwell and weak.
  • Complications: In severe cases, HMPV can lead to impaired lung function, causing shortness of breath.

Diagnosis and differentiation:

  • Symptoms overlap with other respiratory infections like the common cold, flu, or COVID-19, making it essential to seek medical testing for an accurate diagnosis.
  • Professional evaluation is crucial for effective treatment and management.

Read more - Download Covid Vaccination Certificate by Mobile Number

Common causes of human metapneumovirus (HMPV)

Human metapneumovirus is primarily transmitted through contact with respiratory droplets from an infected person. Common causes of human metapneumovirus (HMPV) transmission include:

  • Person-to-person contact: The virus spreads easily through respiratory droplets released when an infected person coughs, sneezes, or talks. Close contact with an infected individual increases the likelihood of transmission.
  • Touching contaminated surfaces: HMPV can survive on surfaces such as doorknobs, light switches, and countertops for hours. Touching these contaminated surfaces and then touching the face, especially the mouth, nose, or eyes, can introduce the virus into the body.
  • Crowded environments: Enclosed spaces where people are in close proximity, such as schools, hospitals, nursing homes, and childcare centres, offer ample opportunity for the virus to spread. These environments are particularly risky during the flu season.
  • Seasonal factors: Infections tend to be more frequent during colder months, typically from winter to early spring, when respiratory viruses like flu and the common cold also circulate more easily.
  • Weakened immune systems: Individuals with compromised immune systems, such as those undergoing cancer treatment, those with chronic illnesses, or the elderly, are at a higher risk of severe infections and complications from HMPV.

Understanding these causes is essential in preventing the spread of HMPV, especially in high-risk settings.

How is human metapneumovirus transmitted?

Human metapneumovirus (HMPV) spreads through respiratory droplets when an infected person coughs or sneezes. It can also be transmitted via direct contact with contaminated surfaces or objects.

What are the factors that increase the risk of HMPV infection?

Risk factors for human metapneumovirus (HMPV) include age (children and elderly are more vulnerable), weakened immune systems, and underlying respiratory conditions. Exposure to infected individuals also raises the risk of transmission.

How is human metapneumovirus (HMPV) diagnosed

Diagnosing HMPV typically involves a combination of clinical evaluation and laboratory tests. Healthcare providers may suspect HMPV if a patient presents with respiratory symptoms during the typical seasonal outbreaks. The following diagnostic steps may be used:

  • Physical examination: A doctor will assess the patient’s symptoms and perform a thorough physical exam to check for signs of respiratory distress, such as wheezing or laboured breathing.
  • Laboratory tests: Laboratory testing, including PCR (polymerase chain reaction) tests, can confirm the presence of the virus by detecting HMPV genetic material in respiratory samples.
  • Blood tests: Blood tests may be used to rule out other infections or complications, such as bacterial pneumonia.
  • Chest X-ray: In severe cases, a chest X-ray may be ordered to check for lung damage or infection, such as pneumonia.
  • Nasopharyngeal swab: A sample of mucus from the throat or nasal cavity may be collected for laboratory testing.

Diagnosing HMPV early is crucial to starting the right treatment and avoiding complications, especially for vulnerable individuals.

Effective treatment options for human metapneumovirus (HMPV)

Currently, there is no specific antiviral treatment for human metapneumovirus (HMPV). However, several treatments are available to manage symptoms and support recovery:

  • Rest: Rest is crucial for allowing the body’s immune system to fight off the virus and promote healing.
  • Hydration: Staying hydrated is essential for overall health and helps the body recover more effectively by supporting the immune system.
  • Over-the-counter medications: Pain relievers like paracetamol or ibuprofen can help reduce fever, alleviate body aches, and provide comfort to the patient.
  • Inhalers and nebulisers: For individuals experiencing wheezing or difficulty breathing, inhalers or nebulisers can help open the airways and make breathing easier.
  • Oxygen therapy: In more severe cases, especially in vulnerable populations such as young children or the elderly, oxygen therapy may be required to ensure sufficient oxygen levels.
  • Antibiotics: Although antibiotics are ineffective against viral infections like HMPV, they may be prescribed if a secondary bacterial infection, such as pneumonia, occurs.

Prompt treatment is important for managing symptoms, preventing complications, and ensuring a smoother recovery, particularly in individuals who are at higher risk of severe illness.

Prevention tips for human metapneumovirus (HMPV)

Preventing HMPV involves taking several hygiene and lifestyle precautions to reduce the spread of the virus. Key prevention tips include:

  • Wash hands regularly: Thorough handwashing with soap and water for at least 20 seconds can help eliminate viruses from the hands.
  • Cover coughs and sneezes: Always cover your nose and mouth with a tissue or elbow to prevent the spread of respiratory droplets.
  • Avoid close contact: Stay away from people who are sick and avoid large gatherings, especially during peak infection seasons.
  • Disinfect commonly touched surfaces: Regularly disinfect door handles, mobile phones, and other surfaces that may be contaminated with the virus.
  • Boost immunity: Maintaining a healthy lifestyle, including proper nutrition, exercise, and sufficient sleep, helps strengthen the immune system.
  • Wear masks: In crowded areas, especially during outbreaks, wearing a mask can reduce the risk of airborne transmission.

By following these simple yet effective preventive measures, the risk of HMPV infection can be significantly reduced.

Read more - How to Get Beneficiary ID For COVID-19 Vaccine

Difference between HMPV and other respiratory infections

While human metapneumovirus (HMPV) shares many symptoms with other respiratory infections like the common cold, influenza, and COVID-19, there are distinct differences that help differentiate each condition.

  • HMPV vs Common Cold: The common cold is caused by various viruses, including rhinoviruses, which typically affect the upper respiratory tract. In contrast, HMPV primarily affects the lower respiratory tract and can lead to more severe complications, especially in vulnerable groups like infants and the elderly.
  • HMPV vs Influenza: Influenza generally causes higher fevers, more intense body aches, and fatigue compared to HMPV. Both infections, however, can lead to severe complications like pneumonia, especially in high-risk populations.
  • HMPV vs COVID-19: COVID-19 is caused by the SARS-CoV-2 virus and tends to result in more severe systemic symptoms, including loss of taste or smell and gastrointestinal issues. While both HMPV and COVID-19 affect the respiratory system, COVID-19 can lead to a broader range of symptoms and more significant long-term complications.

Recognising the differences between these infections is essential for proper diagnosis and treatment, helping to manage the illness effectively and take the necessary precautions.

Conclusion

Human metapneumovirus (HMPV) is a common respiratory infection that can cause serious health complications, particularly in vulnerable populations. Understanding the symptoms, causes, diagnosis, and treatment options is crucial for managing the infection effectively. While no specific antiviral treatment is available, symptom management and preventive measures play a significant role in reducing the impact of HMPV. By maintaining proper hygiene, seeking medical attention when necessary, and following preventive guidelines, the spread of HMPV can be minimised. Early diagnosis and treatment are essential for improving recovery outcomes, especially for children, the elderly, and those with weakened immune systems.

Managing HMPV symptoms and treatment can involve significant medical expenses. Having comprehensive health insurance plans ensures financial protection, covering hospitalisation, diagnostic tests, and treatments, allowing you to focus on recovery without worrying about unexpected healthcare costs. By raising awareness and promoting preventive actions, we can reduce the burden of this infection in communities.

Frequently asked questions

What is Human Metapneumovirus (HMPV), and how does it spread?
Human metapneumovirus (HMPV) is a respiratory virus that primarily affects the lower respiratory tract, leading to cold-like symptoms. It spreads through respiratory droplets from coughing, sneezing, or talking. The virus can also spread via touching contaminated surfaces and then touching the face. HMPV is highly contagious, especially in crowded environments.

Can Human Metapneumovirus (HMPV) be treated at home?
Yes, mild cases of HMPV can typically be managed at home with rest, hydration, and over-the-counter medications like paracetamol to alleviate symptoms. For respiratory difficulties, inhalers or nebulisers may be recommended. It's important to monitor symptoms closely and seek medical advice if they worsen, especially for children or the elderly.

Are there vaccines available for Human Metapneumovirus (HMPV)?
Currently, no specific vaccine is available for HMPV. Research is ongoing, but there is no approved vaccine to prevent the virus. Preventive measures, such as practising good hygiene and avoiding close contact with infected individuals, are the most effective ways to reduce the risk of transmission.

How long does it take to recover from Human Metapneumovirus (HMPV)?
Recovery time from HMPV typically ranges from a few days to two weeks, depending on the severity of the infection and the individual's overall health. Mild cases may resolve in about a week, while severe cases, particularly in infants or the elderly, can take longer. Adequate rest and hydration support the recovery process.

Can human metapneumovirus infection be prevented?

Preventing HMPV involves practising good hygiene, like frequent handwashing, using tissues when coughing or sneezing, and avoiding close contact with infected individuals. Wearing masks can also reduce transmission risk.

How long does the human metapneumovirus infection persist?

HMPV symptoms usually last between 5 to 7 days, although the cough can persist for several weeks in some cases. Recovery time depends on an individual’s health and age.

Is HMPV considered a severe illness?

While HMPV is typically mild in adults, it can cause severe respiratory issues in young children, the elderly, and those with weakened immune systems. In severe cases, it can lead to pneumonia or other complications.

Is HMPV highly contagious?

Yes, human metapneumovirus is highly contagious. It spreads through respiratory droplets, direct contact with infected surfaces, or close interaction with an infected person, especially during cold and flu season.

What treatments are available for HMPV?

There is no specific antiviral treatment for HMPV. Management focuses on relieving symptoms such as fever and cough, with rest, fluids, and over-the-counter medications. Severe cases may require hospitalisation for oxygen support or treatment of respiratory distress.

Show More Show Less

Bajaj Finserv App for all your financial needs and goals

Trusted by 50 million+ customers in India, Bajaj Finserv App is a one-stop solution for all your financial needs and goals.

You can use the Bajaj Finserv App to:

Apply for loans online, such as Instant Personal Loan, Home Loan, Business Loan, Gold Loan, and more.

  • Explore and apply for co-branded credit cards online.
  • Invest in fixed deposits and mutual funds on the app.
  • Choose from multiple insurance for your health, motor and even pocket insurance, from various insurance providers.
  • Pay and manage your bills and recharges using the BBPS platform. Use Bajaj Pay and Bajaj Wallet for quick and simple money transfers and transactions.
  • Apply for Insta EMI Card and get a pre-approved limit on the app. Explore over 1 million products on the app that can be purchased from a partner store on Easy EMIs.
  • Shop from over 100+ brand partners that offer a diverse range of products and services.
  • Use specialised tools like EMI calculators, SIP Calculators
  • Check your credit score, download loan statements, and even get quick customer support—all on the app.
Download the Bajaj Finserv App today and experience the convenience of managing your finances on one app.

Do more with the Bajaj Finserv App!

UPI, Wallet, Loans, Investments, Cards, Shopping and more

GET THE APP

Disclaimer

*T&C Apply - Bajaj Finance Limited (‘BFL’) is a registered corporate agent of third party insurance products of Bajaj Allianz Life Insurance Company Limited, HDFC Life Insurance Company Limited, Future Generali Life Insurance Company Limited, Bajaj Allianz General Insurance Company Limited, SBI General Insurance Company Limited, ACKO General Insurance Limited, ICICI Lombard General Insurance Company Limited, HDFC ERGO General Insurance Company Limited, Tata AIG General Insurance Company Limited, The New India Assurance Company Limited, Cholamandalam MS General Insurance Company Limited, Niva Bupa Health Insurance Company Limited , Aditya Birla Health Insurance Company Limited, Manipal Cigna Health Insurance Company Limited and Care Health Insurance Company Limited under the IRDAI composite CA registration number CA0101. Please note that, BFL does not underwrite the risk or act as an insurer. Your purchase of an insurance product is purely on a voluntary basis after your exercise of an independent due diligence on the suitability, viability of any insurance product. Any decision to purchase insurance product is solely at your own risk and responsibility and BFL shall not be liable for any loss or damage that any person may suffer, whether directly or indirectly. Please refer insurer's website for Policy Wordings. For more details on risk factors, terms and conditions and exclusions please read the product sales brochure carefully before concluding a sale. Tax benefits applicable if any, will be as per the prevailing tax laws.. Tax laws are subject to change. BFL does NOT provide Tax/Investment advisory services. Please consult your advisors before proceeding to purchase an insurance product. Visitors are hereby informed that their information submitted on the website may also be shared with insurers. BFL is also a distributor of other third party products from Assistance Services providers such as CPP Assistance Services Pvt. Ltd., Bajaj Finserv Health Ltd. etc. All product information such as premium, benefits, exclusions, sum insured, value added services, etc. are authentic and solely based on the information received from the respective insurance company or the respective Assistance service provider company.



Note – While we have made all efforts and taken utmost care in gathering precise information about the products, features, benefits, etc. However, BFL cannot be held liable for any direct or indirect damage/loss. We request our customers to conduct their research about these products and refer to the respective product’s sales brochures before concluding their sale.

Show All Text